Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Evaluation of K9 in Subjects With Diabetic Macular Edema (DME) [Phase 1]
Clinical trial update indicates termination of a Phase 1 study evaluating K9 in subjects with Diabetic Macular Edema. The snippet does not r…
-
FDA approval · 2026-04-02FDA Approved: EYLEA HD — Supplemental Application (Regeneron Pharmaceuticals, Inc)
FDA approved a supplemental application for EYLEA HD, a high-dose formulation of aflibercept, expanding the product's labeling.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema [Phase 3]
This Phase 3 trial evaluates the efficacy and safety of 8 mg aflibercept in Chinese participants with diabetic macular edema.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema
This is an observational study sponsored by Bayer evaluating how well aflibercept 8 mg works for visual impairment due to neovascular age-re…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy [Phase 2]
A Phase 2 study of SCD411 in adults with wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, tolerability, pharmacokinetics, and efficacy of RO7446603 alone or in combination with afl…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema [Phase 3]
A Phase 3 trial is planned to compare AVT29 with Eylea HD in diabetic macular edema and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 [Phase 1]
A Phase 1b study evaluating safety, tolerability, pharmacokinetics, and exploratory efficacy of intravitreal OLN324 in diabetic macular edem…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: A Randomized Trial of Pain, Procedure Time, Patient Satisfaction, and Safety [NA]
A randomized trial evaluating speculum-free intravitreal injection using cotton-tipped applicator retraction, assessing pain, procedure time…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]
EyeBiotech Ltd reports a two-part Phase 1/Phase 2 clinical trial evaluating safety in macular edema due to branch retinal vein occlusion and…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema [Phase 3]
This update reports the completion of a Phase 3 trial evaluating PRO-169 for diabetic macular edema.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Hoffmann-La Roche reports a real-world, observational study to gain clinical insights into Roche ophthalmology products across several retin…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema [Phase 1]
This clinical trial entry reports that PRO-169 is being evaluated in Phase 1 for safety and immunogenicity in diabetic macular edema, with t…
-
FDA approval · 2026-03-11FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OZURDEX (dexamethasone intravitreal implant) submitted by Allergan, Inc.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Kamuvudine-9 (K9) in Diabetic Macular Edema [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Kamuvudine-9 (K9) for diabetic macular edema is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
Clinical trial update describing the use of aflibercept in routine medical practice for Japanese participants with neovascular age-related m…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients [EARLY_Phase 1]
An early-phase clinical trial is evaluating the safety and efficacy of LX111 gene therapy in patients with diabetic macular edema. The study…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Study of CU06-1004 in Patients With Daibetic Macular Edema [Phase 2]
This is a Phase 2 clinical trial evaluating CU06-1004 for diabetic macular edema; the study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME [Phase 3]
Phase 3 study investigating the Port Delivery System delivering ranibizumab for diabetic macular edema, comparing it with standard intravitr…
-
EMA approval · 2026-03-04EMA Authorised: Eylea (aflibercept) — Bayer AG
The EMA authorised Eylea (aflibercept) from Bayer AG for multiple ocular indications, including wet age-related macular degeneration, macula…
-
EMA approval · 2026-03-03EMA Authorised: Afqlir (aflibercept) — Sandoz GmbH
The EMA authorised Afqlir (aflibercept) from Sandoz GmbH for retinal conditions including wet age-related macular degeneration, macular edem…
-
CLINICAL_TRIALS withdrawal · 2026-03-02Clinical Trial Update: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes [Phase 4]
The Phase 4 trial comparing Dextenza to prednisolone acetate after cataract surgery in diabetic patients has been withdrawn. No further resu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial evaluating Faricimab treatment response in treatment-naive, underrepresented patients with Diabetic Macular Edema; cu…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema [Phase 2]
A Phase 2 clinical trial is planned to evaluate Lactiplantibacillus plantarum 299v probiotic supplementation in patients with diabetic macul…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients [Phase 4]
A Phase 4 clinical trial protocol comparing dexamethasone intravitreal implant combined with aflibercept versus aflibercept monotherapy in t…